Article

Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome

2021-04-15

Abstract excerpt

<title>Abstract</title> <p>The molecular mechanisms underlying the pathogenesis of COVID-19 has not been fully discovered. This study aims to decipher potentially hidden parts of the pathogenesis of COVID-19, potential novel drug targets, and to identify potential drug candidates. Two gene expression profiles (GSE147507-GSE153970) were analyzed and overlapping differentially expressed genes (DEGs) were selected f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 87a6e207-6687-5051-bff5-f5a5db498501
DOI: 10.21203/rs.3.rs-406292/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptomeDOI 10.21203/rs.3.rs-406292/v1Read

Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation studySemantic proximity Read

Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19Semantic proximity Read

COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics DatasetsSemantic proximity Read

Transcriptome and SARS-CoV-2 biological network directed analysis for better therapeutic developmentSemantic proximity Read

Screening key genes and signaling pathways in COVID-19 infection and its associated complications by integrated bioinformatics analysisSemantic proximity Read

Identification of key genes related to immune cells in patients with COVID-19 via Integrated Bioinformatics-Based AnalysisSemantic proximity Read

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: insights from machine learning and bioinformatics approachesSemantic proximity Read

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity Read

In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposingSemantic proximity Read

Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methodsSemantic proximity Read

Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications.Semantic proximity Read

Transcriptomic Signatures and Repurposing Drugs for COVID-19 Patients: Findings of Bioinformatics AnalysesSemantic proximity Read